Thiazolidinedione-associated congestive heart failure and pulmonary edema

Research output: Contribution to journalArticle

105 Scopus citations

Abstract

Objective: To evaluate the effect of thiazolidinediones on the development of cardiac failure and pulmonary edema during treatment of type 2 diabetes mellitus. Patients and Methods: We retrospectively reviewed the medical records of 6 men (aged 66 to 78 years) treated at our institution between August 1, 2001, and May 21, 2002, who had type 2 diabetes and developed signs and symptoms of congestive heart failure and pulmonary edema after 1 to 16 months of therapy with pioglitazone or rosiglitazone. Results: Four patients had chronic renal insufficiency; only 1 had ischemic cardiomyopathy. Symptoms resolved promptly in all 6 patients after administration of diuretics and discontinuation of the thiazolidinedione. Conclusion: We conclude that thiazolidinediones can cause or exacerbate heart failure and pulmonary edema and should be avoided in patients with left ventricular dysfunction or chronic renal insufficiency.

Original languageEnglish (US)
Pages (from-to)1088-1091
Number of pages4
JournalMayo Clinic Proceedings
Volume78
Issue number9
DOIs
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Thiazolidinedione-associated congestive heart failure and pulmonary edema'. Together they form a unique fingerprint.

  • Cite this